Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061392) titled 'A multicenter retrospective cohort study on the efficacy and safety with teprotumumab versus intravenous glucocorticoid for thyroid eye disease' on June 1.
Study Type:
Observational
Primary Sponsor:
Institute - Nagasaki University Hospital
Condition:
Condition - Thyroid eye disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - There are no randomized controlled trials (RCTs) on the therapeutic effects of the novel treatment with teprotumumab and conventional treatment (steroid-pulse therapy) for active thyroid eye disease (TED), and no guidelines have been establ...